This topic contains a solution. Click here to go to the answer

Author Question: Use of which of the following drugs is contraindicated for a patient receiving aldesleukin ... (Read 14 times)

sjones

  • Hero Member
  • *****
  • Posts: 520
Use of which of the following drugs is contraindicated for a patient receiving aldesleukin (inter-leukin-2)?
 
  a. Calcium channel blocker
  b. Bronchodilator
  c. Nonopioid analgesic
  d. Corticosteroid

Question 2

Which of the following adverse effects of filgastrim (Neupogen) should the patient be directed to treat with acetaminophen?
 
  a. Bone pain
  b. Heartburn
  c. Abdominal pain
  d. Headache



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Chelseyj.hasty

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

ANS: D
Corticosteroids are contraindicated for use during therapy with interleukin-2 because they reduce the antitumor effectiveness of the biologic response modifier.

Answer to Question 2

ANS: A
Bone pain is the most common adverse effect of filgastrim and is due to the extensive bone mar-row regeneration. It can be easily treated with acetaminophen.





 

Did you know?

Drying your hands with a paper towel will reduce the bacterial count on your hands by 45–60%.

Did you know?

Multiple sclerosis is a condition wherein the body's nervous system is weakened by an autoimmune reaction that attacks the myelin sheaths of neurons.

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

The cure for trichomoniasis is easy as long as the patient does not drink alcoholic beverages for 24 hours. Just a single dose of medication is needed to rid the body of the disease. However, without proper precautions, an individual may contract the disease repeatedly. In fact, most people develop trichomoniasis again within three months of their last treatment.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

For a complete list of videos, visit our video library